Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Swiss Multi-center, Randomized, Placebo-controlled Trial on the Efficacy of Baloxavir Marboxil to Reduce Time to Clinical Improvement in Adult Patients Hospitalized for Influenza

NCT06653569 is registered in ClinicalTrials.gov with Dre Pauline Vetter as lead sponsor.

NCT NCT06653569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06653569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Swiss Multi-center, Randomized, Placebo-controlled Trial on the Efficacy of Baloxavir Marboxil to Reduce Time to Clinical Improvement in Adult Patients Hospitalized for Influenza
Lead sponsor
Dre Pauline Vetter
Phase
Phase 3
Overall status
Recruiting
Start date
December 13, 2024
Completion date
September 30, 2027
Enrollment
484 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza disease; flu